Status:
COMPLETED
Effectiveness and Safety of the Colonoscopy Assisted by Endocuff vs. Standard in the Colorectal Cancer Screening
Lead Sponsor:
Hospital Provincial de Castellon
Conditions:
Cancer Colorectal
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
The hypothesis of the present study is to demonstrate that ENDOCUFF VISION® increases the detection rate of adenomas thanks to the improved visibility produced by the retraction of the folds and stabi...
Detailed Description
The main objective of the colorectal cancer screening program (CRC) is the detection of the greatest number of precursor lesions of neoplasms as well as cancerous lesions established in the general po...
Eligibility Criteria
Inclusion
- A) Patients between the ages of 50 and 70 referred for a colonoscopy within the colorectal cancer screening program.
- B) With the ability to provide informed consent
Exclusion
- History of inflammatory bowel disease
- History or suspected obstruction or intestinal pseudo-obstruction located in the colon
- History of colon cancer or polyposic syndromes
- History of colonic stenosis
- History of severe diverticular segments in some region of the colon
- Subjects unable to provide informed consent
- Subjects under treatment with clopidogrel, warfarin, acenocoumarol or other new generation anticoagulants that have not discontinued treatment in accordance with the provisions of these procedures
- Pregnants females
- Subjects who are going to undergo a therapeutic or surveillance endoscopy for follow-up of injuries diagnosed in previous procedures
- Subjects whose baseline status does not allow the completion of the questionnaires necessary for the evaluation of the study objectives.
- History of previous colonic surgery except for appendectomy
- Any medical, psychological, psychiatric, geographic or social problem that is important and uncontrolled that may interfere with the patient's participation in the study or that does not allow adequate follow-up and adherence to the protocol and evaluation of the study results.
Key Trial Info
Start Date :
February 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
822 Patients enrolled
Trial Details
Trial ID
NCT04280393
Start Date
February 10 2020
End Date
November 30 2021
Last Update
November 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Provincial de Castellon
Castellon, Castellon, Spain, 12002